MX9801428A - Compuestos esteroidales que tiene actividad anticonceptiva y anti-osteoporosis. - Google Patents
Compuestos esteroidales que tiene actividad anticonceptiva y anti-osteoporosis.Info
- Publication number
- MX9801428A MX9801428A MX9801428A MX9801428A MX9801428A MX 9801428 A MX9801428 A MX 9801428A MX 9801428 A MX9801428 A MX 9801428A MX 9801428 A MX9801428 A MX 9801428A MX 9801428 A MX9801428 A MX 9801428A
- Authority
- MX
- Mexico
- Prior art keywords
- ring
- steroid compounds
- contraceptive
- steroid
- prevention
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0085—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invencion se refiere a un compuesto esteroidal que tiene la formula (I), que comprende un anillo E, dicho anillo compartiendo átomos de carbono en la posicion 16 y 17 con el anillo D de cinco miembros y siendo alfa con respecto a dicho anillo D. Además, el átomo de carbono en la posicion 17 está substituido con un grupo que comprende un átomo de oxígeno a través de un enlace de CO. La invencion también se refiere a una composicion farmacéutica que comprende dicho compuesto esteroidal. Los compuestos esteroidales de la presente invencion son muy adecuados para usarse en la prevencion o el tratamiento de quejas peri-menopáusicas o menopáusicas, muy preferiblemente para la prevencion o el tratamiento de osteoporosis. Además los compuestos esteroidales de la presente invencion pueden ser usados para propositos anticonceptivos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97102884.0 | 1997-02-21 | ||
EP97102884 | 1997-02-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9801428A true MX9801428A (es) | 1998-12-31 |
MXPA98001428A MXPA98001428A (es) | 1999-02-01 |
Family
ID=
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL129068A0 (en) | Sulfinic acid derivatives and their preparation and use | |
TR200001203T2 (tr) | Yeni birleşik maddeler | |
HUP9900684A2 (hu) | Új 19-nor-pregnén-származékok | |
AP1414A (en) | Controlled release galantamine composition. | |
BG103903A (en) | Nonsteroid (hetero) cyclic substituted acylanylides of mixed gestagenous and androgenous activity | |
DE69325130D1 (de) | N-sulfonyl-2-oxoindol-derivate mit einer affinität für die vasopressin und/oder ocytocin rezeptoren | |
MY101791A (en) | New benzimidazole derivatives | |
SE9100342D0 (sv) | Novel steroid esters | |
GR3023938T3 (en) | 3',5'-ditertbutyl-4'-hydroxyflavones, method for their preparation and pharmaceutical compositions with an antioxidant and antivasoconstricting activity | |
BR9808422A (pt) | Composto, composição farmacêutica, processos para induzir paralisia neuromuscular em um mamìfero e para a preparação de um composto, e, uso de um composto | |
MY111201A (en) | New imidazopyridines | |
BR9709062A (pt) | Composto, composição farmacêutica, e, uso de um composto. | |
CA2229960A1 (en) | Steroid compounds having contraceptive and anti-osteoporosis activity | |
GB2380939B (en) | Treatment or prevention of auto-immune diseases | |
CA2286192A1 (en) | Use of alcohols as additives for plaster and/or mortar | |
MD502G2 (ro) | Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin | |
MY124078A (en) | Eletriptan hydrobromide monohydrate | |
TR200101083T2 (tr) | (7alfa,17alfa)-17-hidroksi- 7-metil-19-nor-17-pregn-5 (10)-en-20-in-3-on içeren yüksek saflıkta bileşim. | |
AP9300589A0 (en) | Novel 17a and 17b substituted acyl-3-carboxy 3,5-diene steroidal compounds, pharmaceutical compositions containing these compounds, and methods for using these compounds to inhibit steroid 5-a-reductase. | |
AU6826700A (en) | Ceramide analogs, process for their preparation and their use as antitumor agents | |
TR200003142T2 (tr) | Yeni oktahidro-6,10-diokso-6H-piridazino [1,2-A] [1,2] diazepin-1-karboksilik asit türevleri. | |
NO20031444D0 (no) | 17<alfa>-fluoralkylsteroider, metoder for fremstilling av disse, og farmasöytiske preparater inneholdende angitte forbindelser | |
AU6826887A (en) | 5-substituted octahydroindolizine analgesics compounds and 7-keto intermediates | |
MX9303392A (es) | Derivados de imidazo benzoxazin-1-ona substituidos y proceso para su preparacion. | |
IL150082A (en) | Unsaturated 14,15 - cyclopropane |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
PD | Change of proprietorship |
Owner name: N.V. ORGANON.* |
|
MM | Annulment or lapse due to non-payment of fees |